Recombinant Erythropoietin in the Prevention of Late Anaemia in Intrauterine Transfused Neonates with Rh-Haemolytic Disease

Publisher： Karger

E-ISSN： 1421-9964|14|5|270-274

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.14, Iss.5, 1999-10, pp. : 270-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erythropoietin as Treatment for Late Hyporegenerative Anemia in Neonates with Rh Hemolytic Disease after in utero Exchange Transfusion

By  

Fetal Diagnosis and Therapy, Vol. 17, Iss. 1, 2002-01 ,pp. : 22-24

Karger

Access to resources Recommend Favorite

Preoperative Administration of Recombinant Human Erythropoietin in Patients Undergoing Gynecologic Surgery

By  

Gynecologic and Obstetric Investigation, Vol. 54, Iss. 1, 2002-09 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Identification of Macrosomic, Normal and Intrauterine Growth Retarded Neonates Using the Modified Neonatal Growth Assessment Score

By  

Fetal Diagnosis and Therapy, Vol. 19, Iss. 1, 2003-12 ,pp. : 58-67

Karger

Access to resources Recommend Favorite

Selective Use of Recombinant Human Erythropoietin in Pregnant Patients with Severe Anemia or Nonresponsive to Iron Sucrose Alone

By  

Fetal Diagnosis and Therapy, Vol. 25, Iss. 2, 2009-06 ,pp. : 239-245

Karger

Access to resources Recommend Favorite

The Impact of Age and Intrauterine Contraception on the Clinical Course of Pelvic Inflammatory Disease

By  

Gynecologic and Obstetric Investigation, Vol. 61, Iss. 2, 2006-02 ,pp. : 65-71

Karger

Access to resources Recommend Favorite